Table 4.
Total cohort | High-risk group | Low-risk group | P-valuea | |
---|---|---|---|---|
(n = 175) | (n = 99) | (n = 76) | ||
Infectious complications, n (%) | 64 (36.6%) | 29 (29.3%) | 35 (46.1%) | 0.018 |
Surgical site infection, n (%) | 19 (10.8%) | 10 (10.1%) | 9 (11.8%) | 0.729 |
Abscess, n (%) | ||||
Wound | 7 (4.0%) | 3 (3.0%) | 4 (5.3%) | 0.639 |
Intra-abdominal | 12 (6.9%) | 7 (7.1%) | 5 (6.6%) | 0.886 |
Pneumonia, n (%) | 14 (8.0%) | 2 (2.0%) | 12 (15.8%) | 0.001 |
Bacteraemia, n (%) | 27 (15.4%) | 11 (11.1%) | 16 (21.1%) | 0.030 |
CRBSI, n (%) | 10 (5.7%) | 4 (4.0%) | 6 (7.9%) | 0.370 |
Urinary tract infection, n (%) | 18 (10.3%) | 4 (4.0%) | 14 (18.4%) | 0.002 |
Antibiotherapy > 7 days, n (%) | 41 (23.4%) | 18 (18.2%) | 23 (30.3%) | 0.081 |
Values in bold are significant at P < 0.05.
CRBSI, catheter-related bloodstream infection.